Showing results (351-360 of 377) with videos related to
Sort By:
Pageof 38
Pain Medicine (Malden, Mass.)|February 22, 2021
Percutaneous Peripheral Nerve Stimulation of the Medial Branch Nerves for the Treatment of Chronic Axial Back Pain in Patients After Radiofrequency AblationTimothy R Deer, Christopher A Gilmore, Mehul J Desai, et al.Nature Medicine|June 8, 2018
Metastatic cancers promote cachexia through ZIP14 upregulation in skeletal muscleGang Wang, Anup K Biswas, Wanchao Ma, et al.Pain Practice : the Official Journal of World Institute of Pain|July 3, 2021
Treatment of chronic axial back pain with 60-day percutaneous medial branch PNS: Primary end point results from a prospective, multicenter studyChristopher A Gilmore, Mehul J Desai, Thomas J Hopkins, et al.The Plant Genome|August 1, 2024
Association study of crude seed protein and fat concentration in a USDA pea diversity panelRenan Uhdre, Clarice J Coyne, Britton Bourland, et al.BMC Plant Biology|March 19, 2013
QTL meta-analysis provides a comprehensive view of loci controlling partial resistance to Aphanomyces euteiches in four sources of resistance in peaCéline Hamon, Clarice J Coyne, Rebecca J McGee, et al.Gastroenterology|March 16, 2019
Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled TrialEvan S Dellon, John T Woosley, Ashley Arrington, et al.Applied Optics|March 8, 2008
Ozone differential absorption lidar algorithm intercomparisonS Godin, A I Carswell, D P Donovan, et al.Translational Psychiatry|December 4, 2018
Striatal dopamine deficits predict reductions in striatal functional connectivity in major depression: a concurrent 11C-raclopride positron emission tomography and functional magnetic resonance imaging investigationJ Paul Hamilton, Matthew D Sacchet, Trine Hjørnevik, et al.Journal of the Neurological Sciences|June 16, 2015
Blood circulating microparticle species in relapsing-remitting and secondary progressive multiple sclerosis. A case-control, cross sectional study with conventional MRI and advanced iron content imaging outcomesJ S Alexander, R Chervenak, B Weinstock-Guttman, et al.Cancer|April 23, 2013
Axitinib and/or bevacizumab with modified FOLFOX-6 as first-line therapy for metastatic colorectal cancer: a randomized phase 2 studyJeffrey R Infante, Tony R Reid, Allen L Cohn, et al.Pageof 38